CAB-LA: Prevention jab that never had its moment, what it leaves behind as LEN arrives
In 2026, as South Africa prepares to introduce lenacapavir, another HIV-prevention injection is fading from view: long-acting cabotegravir, known as CAB-LA in short.... Read more.
A R60 test could help SA find millions more TB patients
A patient arrives at a clinic with a cough that has lingered for weeks. The nurse suspects tuberculosis (TB) and asks for a sputum sample—the phlegm people cough... Read more.
Here’s what’s on South Africa’s 2026 public health agenda
South Africa is a study in contrasts. And the 2026 public health agenda is no exception. Breakthrough HIV prevention medicine has arrived alongside US funding cuts.... Read more.
